References
Abadio AK, Kioshima ES, Teixeira MM, Martins NF, Maigret B, Felipe MS (2011) Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genom 27(12):75.
https://doi.org/10.1186/1471-2164-12-75
Abadio AKR, Kioshima ES, Leroux V, Martins NF, Maigret B, Felipe MS (2015) Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides genus. PLoS ONE 10(11):e0142926.
https://doi.org/10.1371/journal.pone.0142926
Aoki W, Kitahara N, Miura N, Morisaka H, Kuroda K, Ueda M (2012) Profiling of adhesive properties of the agglutinin-like sequence (ALS) protein family, a virulent attribute of Candida albicans. FEMS Immunol Med Microbiol 65(1):121–124.
https://doi.org/10.1111/j.1574-695X.2012.00941.x
Basmaciyan L, Bon F, Paradis T, Lapaquette P, Dalle F (2019) Candida albicans interactions with the host: crossing the intestinal epithelial barrier. Tissue Barriers.
https://doi.org/10.1080/21688370.2019.1612661
Beautrait A, Leroux V, Chavent M, Ghemtio L, Devignes MD, Smaïl-Tabbone M, Cai W, Shao X, Moreau G, Bladon P, Yao J, Maigret B (2008) Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment. J Mol Model 14(2):135–148.
https://doi.org/10.1007/s00894-007-0257-9
Chang YL, Yu SJ, Heitman J, Wellington M, Chen YL (2017) New facets of antifungal therapy. Virulence 8(2):222–236.
https://doi.org/10.1080/21505594.2016.1257457
de Amorim AL, de Lima AVM, Rosário ACAD, Souza ÉTDS, Ferreira JV, Hage-Melim LIDS (2018) Molecular modeling of inhibitors against fructose bisphosphate aldolase from Candida albicans. Silico Pharmacol 6(1):2.
https://doi.org/10.1007/s40203-018-0040-x
Di Pasquale N, Gowers RJ, Carbone P (2014) A multiple time step molecular dynamics algorithm for macromolecules. J Comput Chem 35(16):1199–1207.
https://doi.org/10.1002/jcc.23594
Dong G, Liu Y, Wu Y, Tu J, Chen S, Liu N, Sheng C (2018) Novel non-peptidic small molecule inhibitors of secreted aspartic protease 2 (SAP2) for the treatment of resistant fungal infections. Chem Commun 54(96):13535–13538.
https://doi.org/10.1039/c8cc07810f
Hosseini SS, Ghaemi E, Noroozi A, Niknejad F (2019) Zinc oxide nanoparticles inhibition of initial adhesion and ALS1 and ALS3 gene expression in Candida albicans strains from urinary tract infections. Mycopathologia 184(2):261–271.
https://doi.org/10.1007/s11046-019-00327-w
Hoyer LL, Cota E (2016) Candida albicans agglutinin-like sequence (ALS) family vignettes: a review of als protein structure and function. Front Microbiol 7:280.
https://doi.org/10.3389/fmicb.2016.00280
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(1):33–38
Jiang W, Phillips JC, Huang L, Fajer M, Meng Y, Gumbart JC, Luo Y, Schulten K, Roux B (2014) Generalized scalable multiple copy algorithms for molecular dynamics simulations in NAMD. Comput Phys Commun 185(3):908–916.
https://doi.org/10.1016/j.cpc.2013.12.014
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Khan I, Kanugala S, Shareef MA, Ganapathi T, Shaik AB, Shekar KC, Kamal A, Kumar CG (2019) Synthesis of new bis-pyrazole linked hydrazides and their in vitro evaluation as antimicrobial and anti-biofilm agents: a mechanistic role on ergosterol biosynthesis inhibition in Candida albicans. Chem Biol Drug Des.
https://doi.org/10.1111/cbdd.13509
Kullberg BJ, Arendrup MC (2015) Invasive candidiasis. N Engl J Med 373(15):1445–1456.
https://doi.org/10.1056/NEJMra1315399
Lamoth F, Lockhart SR, Berkow EL, Calandra T (2018) Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother 73(Suppl 1):i4–i13.
https://doi.org/10.1093/jac/dkx444
Li WS, Chen YC, Kuo SF, Chen FJ, Lee CH (2018) The impact of biofilm formation on the persistence of candidemia. Front Microbiol. 9:1196.
https://doi.org/10.3389/fmicb.2018.01196
Lin J, Oh SH, Jones R, Garnett JA, Salgado PS, Rusnakova S, Matthews SJ, Hoyer LL, Cota E (2014) The peptide-binding cavity is essential for Als3-mediated adhesion of Candida albicans to human cells. J Biol Chem 289(26):18401–18412.
https://doi.org/10.1074/jbc.M114.547877
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1–3):3–26
Liu Y, Filler SG (2011) Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 10(2):168–173.
https://doi.org/10.1128/EC.00279-10
Marc G, Araniciu C, Oniga S, Vlase L, Pîrnău A, Duma M, Măruescu L, Chifiriuc MC, Oniga O (2018) New N-(oxazolylmethyl)-thiazolidinedione active against Candida albicans biofilm: potential Als proteins inhibitors. Molecules 23(10):2522.
https://doi.org/10.3390/molecules23102522
Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD (2012) A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148(1–2):126–138.
https://doi.org/10.1016/j.cell.2011.10.048
Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383–e392.
https://doi.org/10.1016/S1473-3099(17)30316-X
Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN (2019) Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997–2016. Open Forum Infect Dis 6(Suppl 1):S79–S94.
https://doi.org/10.1093/ofid/ofy358
Phua AI, Hon KY, Holt A, O'Callaghan M, Bihari S (2019) Candida catheter-related bloodstream infection in patients on home parenteral nutrition: rates, risk factors, outcomes, and management. Clin Nutr ESPEN 31:1–9.
https://doi.org/10.1016/j.clnesp.2019.03.007
Quindós G, Marcos-Arias C, San-Millán R, Mateo E, Eraso E (2018) The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multi resistant Candida auris. Int Microbiol 21(3):107–119.
https://doi.org/10.1007/s10123-018-0014-1
Rodrigues-Vendramini FAV, Faria DR, Arita GS, Capoci IRG, Sakita KM, Caparroz-Assef SM, Becker TCA, Bonfim-Mendonça PS, Felipe M, Svidzinski TIE, Maigret B, Kioshima ES (2019) Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment. PLOS Negl Trop Dis 13(6):e0007441.
https://doi.org/10.1371/journal.pntd.0007441
Rozada AM, Rodrigues FA, Sampiron EG, Seixas FA, Basso EA, Scodro RB, Kioshima ES, Gauze GF (2019) Novel 4-methoxynaphthalene-N-acylhydrazones as potential for paracoccidioidomycosis and tuberculosis co-infection. Future Microbiol 14:587–598.
https://doi.org/10.2217/fmb-2018-0357
Salci TP, Negri M, Abadio AKR, Bonfim-Mendonça P, Capoci I, Caparroz-Assef SM, Donatti L, Felipe MS, Kioshima ES, Svidzinski TI (2017) A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection. Future Microbiol 12:1283–1295.
https://doi.org/10.2217/fmb-2017-0065
Salgado PS, Yan R, Taylor JD, Jones R, Hoyer LL, Matthews SJ, Simpson PJ, Cota E (2011) Structural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicans. Proc Natl Acad Sci USA 108(38):15775–15779.
https://doi.org/10.1073/pnas.1103496108
Semenyuta IV, Kobzar OL, Hodyna DM, Brovarets VS, Metelytsia LO (2019) In silico study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of Candida albicans fructose-1,6-bisphosphate aldolase II. Heliyon 5(4):e01462.
https://doi.org/10.1016/j.heliyon.2019.e01462
Shao J, Tanner SW, Thompson N, Cheatham TE (2007) Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms. J Chem Theory Comput. 3(6):2312–2334.
https://doi.org/10.1021/ct700119m
Silva DR, Sardi JCO, Freires IA, Silva ACB, Rosalen PL (2019) In silico approaches for screening molecular targets in Candida albicans: a proteomic insight into drug discovery and development. Eur J Pharmacol 5(842):64–69.
https://doi.org/10.1016/j.ejphar.2018.10.016
Stierand K, Maass PC, Rarey M (2006) Molecular complexes at a glance: automated generation of two-dimensional complex diagrams. Bioinformatics 22(14):1710–1716.
https://doi.org/10.1093/bioinformatics/btl150
Tascini C, Sozio E, Corte L, Sbrana F, Scarparo C, Ripoli A, Bertolino G, Merelli M, Tagliaferri E, Corcione A, Bassetti M, Cardinali G, Menichetti F (2018) The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data. Infect Dis 50(3):214–219.
https://doi.org/10.1080/23744235.2017.1384956
Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P (2019) Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol 11(52):1–6.
https://doi.org/10.1016/j.mib.2019.04.001
Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J (2018) Epidemiology and clinical features of invasive fungal infection in a US Health Care Network. Open Forum Infect Dis 5(8):187.
https://doi.org/10.1093/ofid/ofy187
Wilson D, Naglik JR, Hube B (2016) The missing link between Candida albicans hyphal morphogenesis and host cell damage. PLoS Pathog 12(10):e1005867.
https://doi.org/10.1371/journal.ppat.1005867
Zarnowski R, Sanchez H, Covelli AS, Dominguez E, Jaromin A, Bernhardt J, Mitchell KF, Heiss C, Azadi P, Mitchell A, Andes DR (2018) Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol 16(10):e2006872.
https://doi.org/10.1371/journal.pbio.2006872
Zhao X, Daniels KJ, Oh SH, Green CB, Yeater KM, Soll DR, Hoyer LL (2006) Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152(Pt 8):2287–2299.